Gray Nancy Ryan
SEC CIK 1714949 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | Dir | 8,930 | — | $1.43M | 8 | 2022-06-10 | 2026-06-05 |
Most active insiders at LGND, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Espinoza Octavio | CFO | — | $13.03M |
| 2 | Reardon Andrew | CLO, Sec | — | $8.77M |
| 3 | Haas Jason | Dir | — | $3.74M |
| 4 | LAMATTINA JOHN L | Dir | — | $2.44M |
| 5 | Gray Nancy Ryan | Dir | — | $1.35M |
| 6 | Aryeh Jason | Dir | — | $1.25M |
| 7 | KOZARICH JOHN W | Dir | — | $1.20M |
| 8 | Sabba Stephen L | Dir | — | $1.16M |
| 9 | Zimmermann Martine | Dir | — | $342.0K |
| 10 | Davis Todd C | CEO, Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-09 19:35 | 2026-06-05 | LGND | LIGAND PHARMACEUTICALS INC | Gray Nancy Ryan | Dir | A - Grant | $0.00 | +836 | 8,930 | +10% | $0 |
| DM | 2025-11-12 | 2025-11-07 | LGND | LIGAND PHARMACEUTICALS INC | Gray Nancy Ryan | Dir | S - Sale+OE | $205.45 | -6,571 | 8,094 | -45% | -$1.35M |
| DM | 2025-11-12 | 2025-11-07 | LGND | LIGAND PHARMACEUTICALS INC | Gray Nancy Ryan | Dir | M - OptEx | $69.58 | +6,571 | 11.1K | +145% | +$457.2K |
| D | 2025-06-10 | 2025-06-06 | LGND | LIGAND PHARMACEUTICALS INC | Gray Nancy Ryan | Dir | A - Grant | $0.00 | +1,209 | 8,094 | +18% | $0 |
| D | 2024-06-18 | 2024-06-14 | LGND | LIGAND PHARMACEUTICALS INC | Gray Nancy Ryan | Dir | A - Grant | $0.00 | +1,252 | 6,885 | +22% | $0 |
| 2024-05-17 | 2024-05-09 | LGND | LIGAND PHARMACEUTICALS INC | Gray Nancy Ryan | Dir | S - Sale | $83.20 | -934 | 5,633 | -14% | -$77.7K | |
| D | 2023-06-13 | 2023-06-09 | LGND | LIGAND PHARMACEUTICALS INC | Gray Nancy Ryan | Dir | A - Grant | $0.00 | +1,142 | 6,567 | +21% | $0 |
| D | 2022-06-13 | 2022-06-10 | LGND | LIGAND PHARMACEUTICALS INC | Gray Nancy Ryan | Dir | A - Grant | $0.00 | +1,004 | 4,706 | +27% | $0 |
Purchase Sale Sale after option exercise All abbreviations